| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |